Preview this article:
Zoom in

Double Synergy Differential Test for detection of plasmid-mediated AmpC-type -lactamases in , Page 1 of 1

| /docserver/preview/fulltext/jmm/59/8/998-1.gif

There is no abstract available for this article.
Use the preview function to the left.


Article metrics loading...

Loading full text...

Full text loading...



  1. Adler H., Fenner L., Walter P., Hohler D., Schultheiss E., Oezcan S., Frei R. 2008; Plasmid-mediated AmpC β -lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes: prevalence at a Swiss university hospital and occurrence of the different molecular types in Switzerland. J Antimicrob Chemother 61:457–458
    [Google Scholar]
  2. Bret L., Chanal-Claris C., Sirot D., Chaibi E. B., Labia R., Sirot J. 1998; Chromosomally encoded AmpC-type β -lactamase in a clinical isolate of Proteus mirabilis . Antimicrob Agents Chemother 42:1110–1114
    [Google Scholar]
  3. CLSI 2008; Performance Standards for Antimicrobial Susceptibility Testing , 18th Informational Supplement. M100-S18 Wayne, PA: Clinical and Laboratory Standards Institute;
  4. D'Andrea M. M., Nucleo E., Luzzaro F., Giani T., Migliavacca R., Vailati F., Kroumova V., Pagani L., Rossolini G. M. 2006; CMY-16, a novel acquired AmpC-type β -lactamase of the CMY/LAT lineage in multifocal monophyletic isolates of Proteus mirabilis from Northern Italy. Antimicrob Agents Chemother 50:618–624 [CrossRef]
    [Google Scholar]
  5. Decre D., Verdet C., Raskine L., Blanchard H., Burghoffer B., Philippon A., Sanson-Le-Pors M. J., Petit J. C., Arlet G. 2002; Characterization of CMY-type β -lactamases in clinical strains of Proteus mirabilis and Klebsiella pneumoniae isolated in four hospitals in the Paris area. J Antimicrob Chemother 50:681–688 [CrossRef]
    [Google Scholar]
  6. Endimiani A., Luzzaro F., Brigante G., Perilli M., Lombardi G., Amicosante G., Rossolini G. M., Toniolo A. 2005; Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to expression of extended-spectrum β -lactamase. Antimicrob Agents Chemother 49:2598–2605 [CrossRef]
    [Google Scholar]
  7. Literacka E., Empel J., Baraniak A., Sadowy E., Hryniewicz W., Gniadkowski M. 2004; Four variants of the Citrobacter freundii AmpC-type cephalosporinases, including novel enzymes CMY-14 and CMY-15, in a Proteus mirabilis clone widespread in Poland. Antimicrob Agents Chemother 48:4136–4143 [CrossRef]
    [Google Scholar]
  8. Luzzaro F., Brigante G., D'Andrea M. M., Pini B., Giani T., Mantegoli E., Rossolini G. M., Toniolo A. 2009; Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type β -lactamase: epidemiology and clinical management. Int J Antimicrob Agents 33:328–333 [CrossRef]
    [Google Scholar]
  9. Mata C., Mirò E., Rivera A., Mirelis B., Coll P., Navarro F. 2010; Prevalence of acquired AmpC β -lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes at a Spanish hospital from 1999 to 2007. Clin Microbiol Infect 16:472–476 [CrossRef]
    [Google Scholar]
  10. Srinivasan U., Zhang L., France A. M., Ghosh D., Shalaby W., Xie J., Marrs C. F., Foxman B. 2007; Probe hybridization array typing: a binary typing method for Escherichia coli . J Clin Microbiol 45:206–214 [CrossRef]
    [Google Scholar]

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error